182 related articles for article (PubMed ID: 23623253)
1. Multidimensional optimization of promising antitumor xanthone derivatives.
Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
[TBL] [Abstract][Full Text] [Related]
2. Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models.
Azevedo CM; Afonso CM; Soares JX; Reis S; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Gales L; Pinto MM
Eur J Med Chem; 2013 Nov; 69():798-816. PubMed ID: 24113365
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety.
Zou Y; Zhao Q; Hu H; Hu L; Yu S; Xu M; Wu Q
Arch Pharm Res; 2012 Dec; 35(12):2093-104. PubMed ID: 23263803
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
9. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.
Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM
Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197
[TBL] [Abstract][Full Text] [Related]
10. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
[TBL] [Abstract][Full Text] [Related]
11. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
12. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
13. Garcinia xanthones as orally active antitumor agents.
Zhang X; Li X; Sun H; Wang X; Zhao L; Gao Y; Liu X; Zhang S; Wang Y; Yang Y; Zeng S; Guo Q; You Q
J Med Chem; 2013 Jan; 56(1):276-92. PubMed ID: 23167526
[TBL] [Abstract][Full Text] [Related]
14. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency.
Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y
Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
17. Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells.
Khonkarn R; Mankhetkorn S; Talelli M; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2012 Jun; 94():266-73. PubMed ID: 22377215
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of a new dimeric xanthone derivative: enhancement of G-quadruplex selectivity and telomere damage.
Franceschin M; Nocioni D; Biroccio A; Micheli E; Cacchione S; Cingolani C; Venditti A; Zizza P; Bianco A; Altieri A
Org Biomol Chem; 2014 Dec; 12(47):9572-82. PubMed ID: 25363232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
